Secondary progression and innate immunity in NMO: A possible link to alemtuzumab therapy?

Kazuo Fujihara, Ichiro Nakashima

Research output: Contribution to journalEditorial

5 Citations (Scopus)
Original languageEnglish
Article numbere38
JournalNeurology: Neuroimmunology and NeuroInflammation
Volume1
Issue number3
DOIs
Publication statusPublished - 2014 Oct

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this